Accordingly, transgenic PTX3 overexpression efficaciously impairs the activation and signaling of the FGF/FGFR system in FGF-driven tumor cell lines, thus affecting tumor growth and metastasis [15, 16, 18]. Here, PTX3 is linked to neoplasm.